Hypertension 2025 Scientific Sessions  /  Rethinking the Box: When Using Less Traditional Blood Pressure Reduction Strategies Delivers More  /  Identity Re-Boot: SGLT2/GLP1RAs as Blood Pressure Drugs
Logo

American Heart Association

  66
  0

Final ID:

Identity Re-Boot: SGLT2/GLP1RAs as Blood Pressure Drugs

  • Derington, Catherine  ( University of Colorado , Aurora , Colorado , United States )
    • Author Disclosures:
    Catherine Derington: DO have relevant financial relationships ; Employee:University of Colorado:Active (exists now) ; Independent Contractor:AHA Journals - Technical Editor for Circulation Cardiovascular Quality and Outcomes:Active (exists now) ; Independent Contractor:Springer/Nature - Associate Editor for Journal of Human Hypertension:Active (exists now) ; Employee:University of Utah:Past (completed)
Meeting Info:

Hypertension 2025 Scientific Sessions

2025

Baltimore, Maryland

Session Info:

Rethinking the Box: When Using Less Traditional Blood Pressure Reduction Strategies Delivers More

Saturday, 09/06/2025 , 04:30PM - 05:30PM

Primary Care

More abstracts on this topic:
Diet Modification in the Management of Hypertension: Can We SaSS it Up?

Marklund Matti

How to implement stress reduction in BP management: Pharmacological and non-phamacological intervention

Hines Anika

More abstracts from these authors:
The Association of Urinary Sodium with Incident Apparent Treatment Resistant Hypertension among African Americans: Findings from The Jackson Heart Study

Sanuade Olutobi, Bress Adam, Addo Daniel, Smith Justin, Carroll Allison, Shimbo Daichi, Talegawkar Sameer, Tucker Katherine, Jacobs Joshua, Derington Catherine

Fee-for-service Medicaid coverage of antihypertensive single pill combination products

Derington Catherine, Jacobs Joshua, Egan Brent, Bress Adam, Bryant Kelsey, Cohen Jordana, Bellows Brandon, King Jordan

You have to be authorized to contact abstract author. Please, Login
Not Available